Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
New US FDA Biologics License Pathway Could Be Missing Link To Reduce Animal Testing
Jul 12 2025
•
By
Bridget Silverman
A new US FDA regulatory pathway for biologics could simplify efforts to reduce reliance on animal testing
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from R&D
More from Advanced Technologies